Treatment of stable angina pectoris as an add-on therapy in adult patients whose condition is not adequately controlled or who are intolerant to first-line antianginal therapies; myocardial protection during coronary revascularization procedures; adjunctive symptomatic treatment of vertigo and tinnitus; improvement of myocardial glucose utilization by inhibiting fatty acid oxidation; reduction of angina attack frequency and nitrate consumption; enhancement of exercise tolerance in angina patients without causing hemodynamic changes; cardioprotective effects against ischemic injury by modulating energy metabolism and reducing intracellular acidosis, sodium/calcium overload, and oxidative stress.